Houston Methodist Sugar Land Hospital

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Transplant Recipients 43%
3. Neoplasms 41%
4. Autologous Transplantation 40%
5. Carcinoma, Intraductal, Noninfiltrating 36%
6. Heart Neoplasms 34%
7. Therapeutics 31%
8. Breast Neoplasms 30%
9. Colorectal Surgery 29%
10. Parkinson Disease 28%
11. Brain Concussion 28%
12. Xylazine 28%
13. Ovarian Neoplasms 28%
14. Spine 26%
15. Trypanosoma 26%
16. Coronavirus 26%
17. Wounds and Injuries 25%
18. Hepatocellular Carcinoma 24%
19. Triple Negative Breast Neoplasms 24%
20. Neoadjuvant Therapy 24%
21. Deep Brain Stimulation 24%
22. Heart 23%
23. Segmental Mastectomy 23%
24. Transplants 23%
25. Ketamine 22%
26. Population 22%
27. Sarcoma 22%
28. Spinal Fusion 22%
29. Nitric Oxide Synthase Type II 21%
30. catalase HPI 21%
31. Veterans 21%
32. Hyperglycemia 21%
33. Tomography 21%
34. Critical Illness 20%
35. INK128 20%
36. Trypanosoma brucei brucei 20%
37. Traumatic Brain Injury 20%
38. Mortality 20%
39. Radiotherapy 19%
40. Lower Extremity 19%
41. Kidney Transplantation 19%
42. Bariatric Surgery 19%
43. Surgeons 18%
44. alvimopan 18%
45. Forelimb 18%
46. End Stage Liver Disease 18%
47. Decision Making 18%
48. Transanal Endoscopic Surgery 18%
49. Drug Therapy 18%
50. Football 18%
51. Psychology 18%
52. Cognition 17%
53. Receptor, Fibroblast Growth Factor, Type 4 17%
54. 2003-2011 Iraq War 17%
55. Loeys-Dietz Syndrome 17%
56. cangrelor 17%
57. Surgical Tape 17%
58. Ado-Trastuzumab Emtansine 16%
59. Abdominal Pain 16%
60. Colectomy 16%
61. SARS Virus 16%
62. Ileus 16%
63. Extremities 16%
64. Histiocytic Necrotizing Lymphadenitis 16%
65. Neoplasm Metastasis 16%
66. pertuzumab 16%
67. Transplantation 16%
68. 130-nm albumin-bound paclitaxel 15%
69. Ulnar Collateral Ligament 15%
70. Lipopolysaccharides 15%
71. Drug Hypersensitivity Syndrome 15%
72. Everolimus 15%
73. Memory 15%
74. Costs and Cost Analysis 15%
75. Shoulder 15%
76. Insulin 15%
77. CJ 21058 15%
78. Versicans 15%
79. Heart Rupture 15%
80. Immune Reconstitution Inflammatory Syndrome 15%
81. Endotoxemia 15%
82. Guidelines 14%
83. taxane 14%
84. Seat Belts 14%
85. Recurrence 14%
86. Mononeuropathies 14%
87. Glucose 14%
88. Lapatinib 14%
89. Minimally Invasive Surgical Procedures 14%
90. Technetium Tc 99m Medronate 14%
91. Pain 14%
92. Medical Futility 14%
93. Students 14%
94. Cancer-Associated Fibroblasts 14%
95. Vena Cava Filters 14%
96. San Francisco 14%
97. Mucormycosis 14%
98. Surgical Oncology 14%
99. omega-N-Methylarginine 14%
100. hydroperoxidase II 14%